Are you or a loved one living with Alzheimer’s disease?
Segal Institute for Clinical Research is currently conducting a clinical research study evaluating the safety
and efficacy of an investigational drug for patients with mild to moderate Alzheimer’s disease.
To qualify, volunteers must:
• Be between the ages of 55 and 85
• Have a diagnosis of probable Alzheimer’s disease
Participants will receive study medication, labs and other diagnostics. Compensation up to $540. Study
can be conducted in English and Spanish. Insurance is not necessary to participate. Transportation
provided at no cost.
If you are interested in learning more, call now toll-free 1-877-734-2588 or visit SegalTrials.com
